Elisabeth Binder Explained

Elisabeth Binder
Birth Place:Vienna, Austria
Fields:Neuroscience
Workplaces:Max Planck Institute of Psychiatry, Munich, Germany
Education:MD, University of Vienna; PhD in Neuroscience, Emory University
Known For:Translational research, psychiatric genetics, clinical neuroscience
Awards:Theodore Reich Award (ISPG), Max Hamilton Award (CINP)
Carus-Preis (2017)

Elisabeth Binder is a medical doctor and neuroscientist specializing in the study of mood and anxiety disorders. She is the director of the Department of Translational Research of the Max Planck Institute of Psychiatry in Munich, Germany. In addition to research, she serves as Vice-President of the European College of Neuropsychopharmacology (ECNP) and is a member of the Executive Committee.[1]

Career

Education

Binder received her MD from the University of Vienna (1995) and completed her PhD in Neuroscience at Emory University in Atlanta, Georgia (2000). Since 2004, she has been an associate professor in the Department of Psychiatry and Behavioral Sciences at Emory University School of Medicine.[2] In 2007 she became a research group leader at the Max Planck Institute of Psychiatry in Munich, Germany. Since 2013 she has been the Director of the Department of Translational Research in Psychiatry of the Institute.[3] [4]

Research focus/interests

As Director of Translational Research in Psychiatry, her major research focus is the identification of mechanisms by which genetic variants and environmental exposure interact to influence stress reactivity and, through these, the risk for affective and anxiety disorders. The ultimate goal of her research is to improve treatment options for patients by better understanding the underlying disease mechanisms.

Awards

Binder has been awarded the Theodore Reich Young Investigator Award, given by the International Society of Psychiatric Genetics and the Max Hamilton Award, bestowed upon scientists who have made outstanding contributions to the field, awarded by the International College of Neuropsychopharmacology (CINP).[2]

In 2016 she became a member of the German Academy of Sciences Leopoldina.[5]

Positions of trust and research assessments

Binder is a member of Munich Center for Neurosciences as well as an associate faculty member of Graduate School of Systemic Neurosciences at Ludwig Maximilian University of Munich. She also serves as Vice-President of the European College of Neuropsychopharmacology (ECNP) and is a member of its Executive Committee.

Publications

Binder has published extensively.

Key publications:

External links

Notes and References

  1. Web site: The Executive Committee . live . https://web.archive.org/web/20150706133535/http://www.ecnp.eu/about-ecnp/who-we-are/executive-committee.aspx . 6 July 2015 . 30 July 2024 . ecnp.eu.
  2. Web site: Elisabeth Binder, MD, PhD . . med.emory.edu/index.html . 4 November 2015 . 27 September 2018 . https://web.archive.org/web/20180927211513/http://psychiatry.emory.edu/faculty/binder_elisabeth.html . dead .
  3. Web site: Binder, Elisabeth . . mpg.de/en . 4 November 2015.
  4. Web site: Dr. Elisabeth Binder . AcademiaNet. 5 November 2015 .
  5. Web site: Elisabeth Binder . German Academy of Sciences Leopoldina . 26 May 2021.

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Elisabeth Binder".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.